Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications

被引:30
作者
Park, Chun-Woong [1 ,2 ]
Mansour, Heidi M. [3 ]
Oh, Tack-Oon [1 ]
Kim, Ju-Young [1 ]
Ha, Jung-Myung [1 ]
Lee, Beom-Jin [4 ]
Chi, Sang-Cheol [1 ]
Rhee, Yun-Seok [5 ,6 ]
Park, Eun-Seok [1 ]
机构
[1] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, Gyeonggi Do, South Korea
[2] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, Chungbuk, South Korea
[3] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Drug Dev Div, Lexington, KY 40536 USA
[4] Ajou Univ, Coll Pharm, Suwon 443749, Gyeonggi Do, South Korea
[5] Gyeongsang Natl Univ, Coll Pharm, Jinju 660751, Gyeongnam, South Korea
[6] Gyeongsang Natl Univ, Res Inst Pharmaceut Sci, Jinju 660751, Gyeongnam, South Korea
关键词
Itraconazole; Phenol; Eutectic mixture; Topical; Skin permeation; SOLID DISPERSION; BETA-CYCLODEXTRIN; DOSE PHARMACOKINETICS; POLYETHYLENE-GLYCOL; MOLECULAR MOBILITY; T-G; FORMULATION; BIOAVAILABILITY; SOLUBILITY; DELIVERY;
D O I
10.1016/j.ijpharm.2012.07.054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aims of this study were to examine the phase behavior of itraconazole-phenol mixtures and assess the feasibility of topical formulations of itraconazole using eutectic mixture systems. Itraconazole-phenol eutectic mixtures were characterized using differential scanning calorimetry, Fourier transform infrared spectroscopy, H-1-nuclear magnetic resonance, and powder X-ray diffractometry. The skin permeation rates of itraconazole-phenol eutectic formulations were determined using Franz diffusion cells fitted with excised hairless mouse skins. Itraconazole can form eutectic compounds with phenol, and the hydrogen-bonding interactions between the carbonyl group in the itraconazole and hydroxyl group in phenol play a major role in itraconazole-phenol eutectic formation. Despite its high molecular weight and hydrophobicity, the drug (i.e., itraconazole) can be permeated through excised hairless mouse skins from itraconazole-phenol eutectic formulations. The findings of this study emphasize the capabilities of the topical application of itraconazole via external preparations. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:652 / 658
页数:7
相关论文
共 40 条
[1]   Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-β-cyclodextrin in infants, children, and adolescents [J].
Abdel-Rahman, Susan M. ;
Jacobs, Richard F. ;
Massarella, Joseph ;
Kauffman, Ralph E. ;
Bradley, John S. ;
Kimko, Hui C. ;
Kearns, Gregory L. ;
Shalayda, Kevin ;
Curtin, Christopher ;
Maldonado, Samuel D. ;
Blumer, Jeffrey L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) :2668-2673
[2]   Phase solubility and inclusion complex of itraconazole with β-cyclodextrin using supercritical carbon dioxide [J].
Al-Marzouqi, AH ;
Shehatta, I ;
Jobe, B ;
Dowaidar, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (02) :292-304
[3]   OPPORTUNISTIC MYCOSES IN THE IMMUNOCOMPROMISED HOST - EXPERIENCE AT A CANCER CENTER AND REVIEW [J].
ANAISSIE, E .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S43-S53
[4]  
Barry B.W., 1983, DERMATOLOGICAL FORMU
[5]   COMPARISON OF THE MULTIPLE DOSE PHARMACOKINETICS OF 2 FORMULATIONS OF ITRACONAZOLE DURING REMISSION INDUCTION FOR ACUTE MYELOBLASTIC-LEUKEMIA [J].
BRADFORD, CR ;
PRENTICE, AG ;
WARNOCK, DW ;
COPPLESTONE, JA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (04) :555-560
[6]   Comparative interaction of 2-hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin with itraconazole:: Phase-solubility behavior and stabilization of supersaturated drug solutions [J].
Brewster, Marcus E. ;
Vandecruys, Roger ;
Peeters, Jef ;
Neeskens, Peter ;
Verreck, Geert ;
Loftsson, Thorsteinn .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (2-3) :94-103
[7]   Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations [J].
Buchanan, Charles M. ;
Buchanan, Norma L. ;
Edgar, Kevin J. ;
Klein, Sandra ;
Little, James L. ;
Ramsey, Michael G. ;
Ruble, Karen M. ;
Wacher, Vincent J. ;
Wempe, Michael F. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (11) :3100-3116
[8]   Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants [J].
Chowdary, KPR ;
Rao, SS .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (11) :1207-1211
[9]  
COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407
[10]   Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14 [J].
Damian, F ;
Blaton, N ;
Naesens, L ;
Balzarini, J ;
Kinget, R ;
Augustijns, P ;
Van den Mooter, G .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (04) :311-322